Home > Webcasts >

Implantable Device Credit Reporting: Intense Federal Audits Continue


Get vast insight into the current implantable medical device credit requirements, how to report these requirements correctly and the best practices to implement a strategy in your facility.

Price: $229.00

Product Code: R032317


Description Biographies

Medical device credit reporting continues to be targeted by the OIG. The result: many hospitals are faced with hundreds of thousands of dollars in repayments. That's because many facilities still don't know how to report credits, when to report credits and for which replacement devices.

The problem: you need to know how to report device credits, especially when using the confusing device credit modifiers. You also need to know how to calculate correct device credit percentages. And there are more problems: new developments of vendor-wide device recalls and new reporting requirements for initially-placed implantable device credits must be followed. Plus, Condition Code 53 has added complications to the process.

The solution: attend the upcoming webcast with healthcare expert Michael Calahan, as he walks you through all the traps that can snare your facility or ASC when reporting device credits.

Learning Objectives

From this essential webcast, you will learn...
  • 2017 rules for mandatory device credit reporting and review the top OIG findings germane to federal device credit audits
  • Obscure rules for ASC reporting including modifiers, and learn the common errors in ASC device credit reporting
  • Prior years' reporting methodologies still targeted by the OIG and federal entities that you must know and be able to explain
  • How to handle recent vendor-wide device recalls and learn about Condition Code 53; review how “replacement” devices differ from “initially-placed” devices, and how to report each in a device credit scenario
  • Best practices and cross-departmental workflow protocols including developing or refining your P&Ps around these important issues